LC
GMAB icon

Lindbrook Capital’s Genmab GMAB Stock Holding History

Lindbrook Capital’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$17.6K Sell
901
-950
-51% -$19.9K ﹤0.01% 1409
2024
Q4 		$38.6K Buy
1,851
+950
+105% +$20.9K ﹤0.01% 929
2024
Q3 		$22K Buy
901
+20
+2% +$535 ﹤0.01% 1246
2024
Q2 		$22.1K Sell
881
-220
-20% -$6.24K ﹤0.01% 1191
2024
Q1 		$32.9K Sell
1,101
-210
-16% -$6.17K ﹤0.01% 966
2023
Q4 		$41.7K Sell
1,311
-103
-7% -$3.23K ﹤0.01% 820
2023
Q3 		$49.9K Sell
1,414
-23
-2% -$876 0.01% 690
2023
Q2 		$54.6K Buy
1,437
+28
+2% +$1.12K 0.01% 687
2023
Q1 		$53.2K Buy
1,409
+20
+1% +$769 0.01% 669
2022
Q4 		$58.9K Buy
1,389
+158
+13% +$6.51K 0.01% 634
2022
Q3 		$40K Buy
1,231
+326
+36% +$11.4K 0.01% 728
2022
Q2 		$29K Sell
905
-290
-24% -$9.4K ﹤0.01% 850
2022
Q1 		$43K Sell
1,195
-60
-5% -$2.06K 0.01% 722
2021
Q4 		$50K Sell
1,255
-10
-0.8% -$417 0.01% 716
2021
Q3 		$55K Buy
1,265
+100
+9% +$4.49K 0.01% 412
2021
Q2 		$48K Sell
1,165
-110
-9% -$4.25K 0.01% 489
2021
Q1 		$42K Buy
1,275
+130
+11% +$4.89K 0.01% 500
2020
Q4 		$47K Sell
1,145
-19
-2% -$710 0.01% 418
2020
Q3 		$43K Sell
1,164
-831
-42% -$30K 0.01% 390
2020
Q2 		$68K Buy
1,995
+505
+34% +$13.8K 0.02% 287
2020
Q1 		$32K Sell
1,490
-1,350
-48% -$30.1K 0.01% 420
2019
Q4 		$63K Buy
+2,840
New +$62K 0.02% 370

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Lindbrook Capital's GMAB Position: Q1 2025 in Review

Lindbrook Capital reduced its Genmab (GMAB) stake by 51% in Q1 2025, selling an estimated $19.9K and leaving 901 shares worth $17.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1409.

Lindbrook Capital first reported a position in GMAB in Q4 2019 and has held it in 22 quarters since. The position peaked at $68K in Q2 2020. 220 funds tracked by Wall St. Rank hold GMAB as of Q1 2025.

  • Lindbrook Capital held 901 shares of Genmab worth $17.6K as of Q1 2025.
  • Lindbrook Capital sold 950 Genmab shares in Q1 2025, an estimated $19.9K.
  • Genmab made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1409 holding.
  • Lindbrook Capital first reported a position in Genmab in Q4 2019 and has held it in 22 quarters since.
  • Lindbrook Capital's Genmab position peaked at $68K in Q2 2020.
  • 220 funds tracked by Wall St. Rank held Genmab as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.